NCT04871399 Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
| NCT ID | NCT04871399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Turin, Italy |
| Condition | Colon Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 416 participants |
| Start Date | 2020-07-13 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 416 participants in total. It began in 2020-07-13 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An Italian randomized controlled trial parallel-group in patients with a malignant tumor of the right or proximal transverse colon requiring right hemicolectomy.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists(ASA) grade I-III. * Right colon cancer (\*The right-sided location of the cancer is defined as the location from the caecum up to the proximal third of the transverse colon), preoperative assessment of tumor stage T2-T4a, any N or T any N+ according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015); no distant metastasis. * Informed consent Exclusion Criteria: * Age \> 85 years old. * T1, N0 * T4b, any N * BMI \> 30. * Metastatic disease (Abdominal and chest CT scan will be mandatory to exclude distant metastasis.) * American Society of Anesthesiologists(ASA) grade IV. * History of cancer in recent 5 years. * Need for Emergency surgery. * Infectious disease requiring treatment. * Pregnancy. * Use of systemic steroids. * No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.
Contact & Investigator
Maurizio Degiuli, Professor
PRINCIPAL INVESTIGATOR
University of Turin, Department of Oncology
Frequently Asked Questions
Who can join the NCT04871399 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Colon Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04871399 currently recruiting?
Yes, NCT04871399 is actively recruiting participants. Contact the research team at mariosolej@gmail.com for enrollment information.
Where is the NCT04871399 trial being conducted?
This trial is being conducted at Grosseto, Italy, Sesto San Giovanni, Italy, La Spezia, Italy, Candiolo, Italy and 10 additional locations.
Who is sponsoring the NCT04871399 clinical trial?
NCT04871399 is sponsored by University of Turin, Italy. The principal investigator is Maurizio Degiuli, Professor at University of Turin, Department of Oncology. The trial plans to enroll 416 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.